Acute hematogenous osteomyelitis involving two or more distinct skeletal sites simultaneously, where a bloodborne infectious organism — most commonly Staphylococcus aureus — seeds multiple bones during a single acute episode.
Verified May 8, 2026 · 5 sources ↓
- Status
- Billable
- Chapter
- 13
- Related CPT
- 19
- Region
- Multi-region
Documentation tips
What should appear in the chart to support M86.09.
Source · Editorial brief grounded in 5 cited references ↓
- Document each affected bone or anatomical site by name — 'right femur and left tibia' is sufficient to justify multiple sites; vague language like 'bilateral bone infection' may not survive audit.
- Record the mechanism explicitly as hematogenous: note the presumed or confirmed primary source of bacteremia (e.g., urinary tract infection, central line, skin infection) to distinguish M86.0x from M86.1x (direct inoculation).
- Capture the infectious organism whenever identified — blood culture, bone biopsy, or wound culture results support the required B95–B97 secondary code and strengthen medical necessity.
- Document acuity markers: symptom onset timeline (days, not months), fever, CRP/ESR elevation, and MRI findings (marrow edema, periosteal reaction) that confirm acute rather than chronic disease.
- If the patient is a child or neonate, document age explicitly — pediatric hematogenous osteomyelitis at multiple sites carries different differential considerations and may affect clinical management documentation.
Related CPT procedures
Procedure codes commonly billed with M86.09. Linking the right diagnosis to the right procedure is what establishes medical necessity.
Source · CMS LCDs · AAOS specialty guidance · claims-pattern analysis
Common coding pitfalls
The recurring mistakes coders make with M86.09 and adjacent codes.
Source · Editorial brief grounded in CDC ICD-10-CM tabular guidance, AAOS coding references, and cited references ↓
- Omitting the B95–B97 organism code when culture results are in the chart — the tabular 'use additional code' instruction makes this mandatory, not optional, when the pathogen is documented.
- Using M86.09 for direct-inoculation osteomyelitis at multiple sites (e.g., post-surgical infection at two joints) — that presentation belongs in M86.1x, not M86.0x.
- Defaulting to M86.09 when only one site is clinically confirmed but the note is vague; single-site acute hematogenous osteomyelitis requires a site-specific code (M86.01–M86.08) or M86.00 for unspecified site.
- Confusing M86.09 with chronic multifocal osteomyelitis (M86.39) — chronic disease requires separate documentation of duration and failed acute treatment, not merely recurrence.
- Failing to code the underlying source of bacteremia as an additional diagnosis when it is documented and actively managed during the same encounter.
Clinical context
Source · Editorial summary grounded in 5 cited references ↓
M86.09 applies when acute hematogenous osteomyelitis is confirmed at multiple anatomical sites in the same patient during the same acute episode. The hematogenous mechanism distinguishes this subcategory from M86.1x (other acute osteomyelitis, which covers direct inoculation from open wounds, fractures, or surgical procedures). Use M86.09 only when the physician explicitly documents multiple sites; if a single site is affected, select the site-specific code from M86.01–M86.08.
This code sits under parent M86.0 (Acute hematogenous osteomyelitis). The ICD-10-CM tabular instructs coders to use an additional code from B95–B97 to identify the infectious organism when documented — do not skip that secondary code if the organism is known. The tabular also requires a separate code for any associated infectious disease when applicable.
M86.09 is distinct from chronic multifocal osteomyelitis (M86.3x) and subacute osteomyelitis (M86.2x). Acuity is determined by clinical course — rapid onset over days, fever, elevated inflammatory markers — not solely by imaging. If the physician documents 'osteomyelitis' without specifying acute vs. chronic or hematogenous vs. direct inoculation, do not default to M86.09; query or fall back to M86.9 (unspecified).
Sibling codes
Other billable codes under M86.0 (laterality / anatomic variants).
Frequently asked questions
Source · Generated from the editorial pipeline, verified against 5 cited references ↓
01When does osteomyelitis at two sites qualify for M86.09 vs. two separate site-specific codes?
02Is a B95–B97 organism code always required with M86.09?
03How do I distinguish acute hematogenous (M86.09) from other acute osteomyelitis at multiple sites?
04Can M86.09 be used for neonatal or pediatric patients?
05What if the physician documents 'multifocal osteomyelitis' without specifying acute or chronic?
06Does M86.09 require a 7th character extension?
07Which imaging findings best support M86.09 in the documentation?
Sources & references
Editorial content was developed using the following public sources. Last verified May 8, 2026.
- 01CDC ICD-10-CM Tabular List 2026 (effective October 1, 2025)
- 02icd10data.comhttps://www.icd10data.com/ICD10CM/Codes/M00-M99/M86-M90/M86-/M86.09
- 03findacode.comhttps://www.findacode.com/news/icd10-osteomyelitis-documentation.html
- 04aapc.comhttps://www.aapc.com/codes/icd-10-codes/M86.09
- 05unboundmedicine.comhttps://www.unboundmedicine.com/icd/view/ICD-10-CM/893162/1/M86_09___Acute_hematogenous_osteomyelitis_multiple_sites
Mira AI Scribe
Mira's AI scribe captures the site-by-site bone involvement, documented bacteremia source, culture and sensitivity results, onset timeline, and acute inflammatory markers (CRP, ESR, WBC) from the encounter note. This prevents a drop to M86.9 (unspecified osteomyelitis), ensures the mandatory B95–B97 organism code is populated, and preserves the hematogenous mechanism designation that differentiates M86.09 from direct-inoculation codes.
See how Mira captures M86.09 documentation